FDA Restarts Rulemaking To Establish Criteria For "Waived" CLIA Status
This article was originally published in The Gray Sheet
Executive Summary
FDA's Division for Clinical Laboratory Devices is planning to hold a public meeting this fall to discuss proposed criteria for categorizing laboratory tests as "waived" from Clinical Laboratory Improvement Act requirements, staffers report.